The startup, Preventive, has raised $30 million and established its headquarters in San Francisco, promising to “address devastating genetic conditions.” To biotech optimists, it’s a noble vision. To critics, it is something else entirely: the prototype for a future where elite-funded labs design the next generation of humanity—outside democratic oversight, outside public scrutiny, and outside moral boundaries. And if the dystopian fear feels exaggerated, consider the bigger picture: Preventive’s mission is currently illegal in the U.S., UK, and many other countries. So why would some of the most powerful men in tech be funneling money into something governments have explicitly banned? DoD Scientist: Bill Gates' Chemtrails Program Designed to Kill '100 Million Americans' by 2050 Preventive’s pitch is simple: use gene editing on human embryos to eliminate hereditary diseases before birth. A modern miracle, at face value. But critics warn that Height. Intelligence. Personality. Physical …